Abstract
Sialic acids (or ulosonic acids) are a family of acidic ketoses (including neuraminic acid, KDN and KDO) that are found at the non-reducing terminus of many glycoconjugates. These saccharide residues are recognized ligands of protein lectins and are removed in the first step in glycoconjugate catabolism. Moreover, sialic acid containing carbohydrates, such as glycolipid gangliosides (i.e. GM3), glycopeptides (i.e. Tn) and polysaccharides (i.e. polysialic acid or colominic acid) play important biological roles. Thus, they represent important targets in natural product synthesis. This review examines the application of sialic acids as donors in glycosylation reactions. The synthesis of protected sialic acid donors and challenges associated with their use in the synthesis of heteronuclear and carbon glycosides are discussed.
Keywords: Sialic Acid, glycoconjugate, carbohydrates, polysialic, colominic
Current Organic Synthesis
Title: Sialic Acid Donors: Chemical Synthesis and Glycosylation
Volume: 1 Issue: 1
Author(s): Dino K. Ress and Robert J. Linhardt
Affiliation:
Keywords: Sialic Acid, glycoconjugate, carbohydrates, polysialic, colominic
Abstract: Sialic acids (or ulosonic acids) are a family of acidic ketoses (including neuraminic acid, KDN and KDO) that are found at the non-reducing terminus of many glycoconjugates. These saccharide residues are recognized ligands of protein lectins and are removed in the first step in glycoconjugate catabolism. Moreover, sialic acid containing carbohydrates, such as glycolipid gangliosides (i.e. GM3), glycopeptides (i.e. Tn) and polysaccharides (i.e. polysialic acid or colominic acid) play important biological roles. Thus, they represent important targets in natural product synthesis. This review examines the application of sialic acids as donors in glycosylation reactions. The synthesis of protected sialic acid donors and challenges associated with their use in the synthesis of heteronuclear and carbon glycosides are discussed.
Export Options
About this article
Cite this article as:
Ress K. Dino and Linhardt J. Robert, Sialic Acid Donors: Chemical Synthesis and Glycosylation, Current Organic Synthesis 2004; 1 (1) . https://dx.doi.org/10.2174/1570179043485448
DOI https://dx.doi.org/10.2174/1570179043485448 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications
Current Drug Targets The Role of Natural Products in the Ligand Deorphanization of TRP Channels
Current Pharmaceutical Design A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the Development of an Anti-Tumor Immune Response
Current Gene Therapy Targeted Ultrasound Imaging of Cancer: An Emerging Technology on its Way to Clinics
Current Pharmaceutical Design Microbicides for Prevention of Transmission of Sexually Transmitted Diseases
Current Pharmaceutical Design Role of Moving Average Analysis for Development of Multi-Target (Q)SAR Models
Mini-Reviews in Medicinal Chemistry MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Natural Compounds A Weapon to Ameliorate Breast Cancer Cells: A Review
Anti-Cancer Agents in Medicinal Chemistry Xanthone Derivatives: New Insights in Biological Activities
Current Medicinal Chemistry Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Current Pharmaceutical Design Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?
Current Pharmaceutical Design The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Drug Design Reviews - Online (Discontinued) Applications of Molecular Imaging in Cancer Gene Therapy
Current Gene Therapy The Role of Streptokinase as a Virulence Determinant of Streptococcus pyogenes – Potential for Therapeutic Targeting
Current Drug Targets The Potential of Flavonoids and Tannins from Medicinal Plants as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry In Silico Study and Cytotoxicity of the Synthesized Open-chain Analogues of Antimycin A3 Against HEP-2 Laryngeal Cancer Cells
Current Cancer Therapy Reviews Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Melatonin and Renal Protection: Novel Perspectives from Animal Experiments and Human Studies (Review)
Current Pharmaceutical Design The Relevance of Microdialysis for Clinical Oncology
Current Clinical Pharmacology The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets